Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

aTyr Pharma, Inc.

NASDAQ: LIFEHealthcare / Biotechnology / USA
0.5600-0.0200-3.45%Vol 929 5661Y Perf -85.99%
Jan 17th, 2019 16:00
BID0.5600 ASK0.5800
Open0.6600 Previous Close0.5800
Pre-Market0.64 After-Trading0.61
 0.06 10.34%  0.05 8.93%
Target Price
0.88 
Analyst Rating
Hold 3.00
Potencial %
57.14 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/50 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/94 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/99 
Income Ranking
 —    -
Market Cap (mil)17 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
4.71 
Earnings Date
13th Nov 2018

Today's Price Range

0.56000.6900

 

52wk Range

0.38004.20

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
30.23%
3 Months
-16.42%
6 Months
-37.08%
1 Year
-85.99%
3 Years
-90.57%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
LIFE0.5600-0.0200-3.45
AAPL155.860.92000.59
GOOG1 089.908.93000.83
MSFT106.120.74000.70
XOM72.130.49000.68
WFC49.230.29000.59
JNJ129.091.05000.82
FB148.300.76000.52
GE9.140.16001.78
JPM102.920.42000.41
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
5.20
Current Ratio
5.40
Long Term Debt to Total Capital
0.21
Total Debt to Equity
0.46
Interest Coverage
-
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
0.41
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-0.60
Cash Flow Per Share
-1.22
Price to Tangible Book
0.41
Book Value per Share
1.30
Enterprise Value (in ths.)
-22 035
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-242.73
ROE last 12 Months
-71.30
Return on Assets (5Y Avg)
-51.98
ROA last 12 Months
-51.43
Return on Capital (5Y Avg)
-93.28
ROC last 12 Months
-55.16
Return on invested Capital Q
-11.69
Return on invested Capital Y
-61.68
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.30-0.2420.00
Q02 2018-0.34-0.35-2.94
Q01 2018-0.35-0.36-2.86
Q04 2017-0.43-0.399.30
Q03 2017-0.51-0.4315.69
Q02 2017-0.57-0.5110.53
Q01 2017-0.55-0.56-1.82
Q04 2016-0.61-0.5313.11
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.1932.14Positive
12/2018 FY-1.1312.40Positive
3/2019 QR-0.2031.03Positive
12/2019 FY-0.8232.23Positive
Next Report Date-
Estimated EPS Next Report-0.30
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume929 566
Shares Outstanding (in ths.)30 020
Trades Count1 285
Dollar Volume533 228
Avg. Volume355 721
Avg. Weekly Volume707 672
Avg. Monthly Volume338 613
Avg. Quarterly Volume440 027

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

46%54%

Bearish Bullish

54%46%

Bearish Bullish

72%28%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
1 (25.00 %)
1 (25.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (100.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Moderate Buy
2.50
Moderate Buy
2.50

There are no comments yet.

News